Austin, April 12, 2025 (Globe Newswire) – Women’s health diagnostics market and growth analysis:
According to the latest report by SNS Insider, the Women’s health diagnostic market was estimated at $ 25.30 billion in 2023 and is expected to reach USD 49.00 billion by 2032, developing a 7.64% TCAC during the forecast period from 2024 to 2032.
The ascending trajectory of the market is fueled by increased awareness of the health problems of women, progress in diagnostic technologies and the growing prevalence of chronic diseases and linked to lifestyle in women. Innovations in genetic tests, imaging technologies and research on biomarkers transform the way in which conditions such as breast cancer, cervical cancer and reproductive health disorders are diagnosed and treated.
Get an example of a report on the women’s health diagnostics market @ https://www.snsinsider.com/sample-request/5775
Market analysis
The growing prevalence of diseases such as breast cancer, cervical cancer and osteoporosis stimulate early detection demand, prioritizing precise and effective diagnostic solutions. High health expenses, government funding for women’s health programs and early adoption of advanced diagnostic technologies in the region stimulate its growth, as the United States has held a share of 38% of the global market in 2023. Breast cancer is the most common cancer in American women, with more than 300,000 cases of each year according to the centers for Disease Control and Prevention (CDC) request for early diagnostic solutions. The increase in awareness, technological developments and health care investments are helping the global market for early detection of diseases in women, such as breast cancer, cervical cancer and osteoporosis, achieved strong growth. The market is dominated by the United States with a share of 38% in 2023 with in-depth health expenses, solid government programs, for example, the National Program for the Early Detection of Cancer of the Breast and the Célé (NBCCEDP) and the early adoption of innovative diagnostic tools, for example 3D mammography, HPV tests and IA-based imaging systems.
Technological innovation is a key market engine, with progress such as liquid biopsies, genetic tests and portable bone density scanners improving the accuracy and accessibility of the diagnosis. In addition, artificial intelligence (AI) in imaging and diagnosis helps to alleviate human errors while increasing early detection rates. The increase in awareness raising via defense organizations and digital health platforms also stimulates market growth because it motivates more women to opt for regular screening. However, challenges such as high diagnostic costs, disparities in access to health care and cultural barriers in certain regions can hinder growth.
The main women’s health diagnostic companies are profiled in the report
- F. Hoffmann-la Roche Ltd. – Cobas HPV test, Cobas Mammography Solutions, Electsys Anti-Müllerian Hormone (AMH) Test, Ventana Her2
- Hologic, Inc. – Pap Thinprep test, Genius 3D Mammography System, Aptima HPV Assay, Panther System
- Quest Diagnostics Incorporated – BRCA Even (BRCA1 / BRCA2 test), HPV and PAP co -test, full hormonal panel for women’s health, Materit 21 Plus (NIP)
- Abbott-Alinity M HPV assault, Dosage of the Estradiol architect, Total β-HCG test I-Stat, HPV test at real risk in real time
- BD (Becton, Dickinson and Company) – BD Surepath Liquid Based Pap Test, BD ONCLARITY HPV ASSAY, BD MAX Vaginal Panel, BD ALLOW VPIII Microbial identification
- Ge Healthcare – Senographer Pristina Mammography System, Invenia Abus (Automated Mammary Ultrasound System), Voluson ultrasound series
- Koninklijke Philips NV – Affiniti ultrasound system, Epiq women’s health ultrasound, microdose if mammography
- Aspira Women’s Health – Ova1 Test, Overa Test
- Thermo fisher Scientific Inc. – ion torrent ngs for women’s health, proflex pcr system, suretct in real time dosages
- Cardinal Health, Inc. – Women’s health test solutions, pregnancy and fertility test kits
- Siemens AG – Mammomat Revelation Mammography System, Addia Centaur HPV Assay, Atellica IM Estradiol Assay
- Perkinelmer Inc. – DELFIA XPRESS HCG test, VANADIS NIPT, EEVA test for IVF
Scope of the report on the diagnostics for the health of women
| Attribute report | Details |
| Market size in 2023 | 25.30 billion dollars |
| Market size by 2032 | $ 49.00 billion |
| Tcac | TCAC from 7.64% from 2024 to 2032 |
| Basic year | 2023 |
| Forecast period | 2024-2032 |
| Historical data | 2020-2022 |
| Key regional coverage | North America (United States, Canada, Mexico), Europe (Eastern Europe (Poland, Romania, Hungary, Turkey, the rest of Eastern Europe) Western Europe) Germany, France, United Kingdom, Italy, Asia-Pacific, China, India, Japan, South Korea, Vietnam, Singapore, Australia, Resie de Asia Pacific), Middle East (Middle East (One, Union, Austral Egypt, Saudi Arabia, Qatar, rest of the Middle East)), Africa (Nigeria, South Africa, rest of Africa), Latin America (Brazil, Argentina, Colombia remains from Latin America) |
Market segmentation
By request
In 2023, the cancer diagnosis segment dominated the market with a share of income of 33.03%, which can be attributed to the growing prevalence of breast and cervical cancers. The cancer diagnosis segment seems to lead to options such as mammography, MRI and liquid biopsy tests for breast cancer are little available from many people available, added by the government’s detection initiatives. In the United States, one in 8 women will develop breast cancer, according to the CDC, creating a need for early detection tools. Diagnostics for cervical cancer as well as PAP smear and HPV tests are another major contributor, WHO pleading for overall elimination via more widespread screening. Other critical applications based on imaging include infectious disease tests (HPV and HIV), osteoporosis diagnostics (Dexa) and pregnancy and fertility tests (ultrasound or hormonal trials). Innovative technologies such as IMA imaging and portable diagnostic devices also accelerate market growth.
By final use
The market was dominated by hospitals in 2023, with the share of the highest income, and this trend should continue, as hospitals remain the main service locations for a range of diagnostic tests. The presentation of advanced imaging systems, reproductive radiologists and high -patient volumes, national hospital systems are essential women’s drug and diagnostic partners. Diagnostic laboratories have climbed closely, stimulated by the tendency to outsource specific tests, such as genomic profiling or hormonal level assessment. Adoptions in clinics and home environments are stimulated by the rise in home HPV tests and home fertility and Home Fertility tests that are approved by FDA is becoming more and more popular. Nor do we forget government initiatives, such as free mammography programs in the United States and Europe, which strengthen hospital diagnostics.
Need research on personalization on the women’s health diagnostics market, now ask @ https://www.snsinsider.com/enquiry/5775
Segmentation of the women’s health diagnostics market
By request
- Cancer
- Infectious diseases
- Osteoporosis
- Pregnancy and fertility
- Prenatal
By final use
- Hospitals
- Laboratory
- Home care
- Others
Regional analysis
North America also dominated the market in 2023, represented 44.31% of world income, the United States representing 38%. This is due to high costs of health care, a high diagnostic infrastructure and government programs such as the National Program for the Early Detection of Breast and the Col of the Uterus (NBCCEDP). There are around 300,000 new cases of breast cancer diagnosed each year by centers for Disease Control and Prevention, and the demand for early detection tools is high. Europe had the most important part because of nations like Germany and the United Kingdom have promoted national cancer screening programs. The EU cancer plan set a goal for 90% of eligible women through the block to receive breast cancer screening by 2025, which has further increased the adoption of diagnostics.
The quickest growth market is found in the Asia-Pacific region, which is motivated by higher health investments, increasing awareness and an improvement in diagnostic facilities. Countries of which India and China can see the case of TPH tests and the transportable ultraviolet adoption, reinforced via regimes of the authorities such as Ayushman Bharat.
Recent developments
- The new generation 3D mammography system, launched by Hologic Inc., in 2024 with IMA -powered imaging to improve the early diagnosis of breast cancer.
- In March 2024, Siemens Healthineers obtained approval from the FDA for its high risk DNA test of human papillomavirus (HPV), progressing the accuracy of the cervical cancer screening.
Buy a single user PDF of the analysis of the diagnostics for women’s health and the Outlook 2024-2032 @ report https://www.snsinsider.com/checkout/5775
Table of contents – Major key points
1. Introduction
2. Summary
3. Research methodology
4. Impact analysis on market dynamics
5. Statistical reports of information and trends
5.1 Incidence and prevalence of women’s health problems (2023), by region
5.2 Technological advancement in women’s health diagnostics (2023-2032)
5.3 Additional rate of early screening programs and preventive diagnostics (2023), by region
5.4 Home testing trends and at the point of service for women’s health (2020-2032)
5.5 Regulatory and political trends having an impact on women’s health diagnostics (2023-2032)
6. Competitive landscape
7. Women’s health diagnostics market by application
8. Women’s health diagnostics market by final use
9. Regional analysis
10. Business profiles
11. Using and best practices
12. Conclusion
Access the full report Details of the market analysis of women’s health diagnostics and prospects 2024-2032 @ https://www.snsinsider.com/reports/womens-health-diagnostics-market-5775
(For more information or need for customization research we send a letter to info@snsinsider.com))
About Us:
SNS Insider is one of the main market and consulting agencies that dominate the market research industry worldwide. The objective of our company is to give customers the knowledge they need to operate in changing circumstances. In order to give you current and precise market data, consumer information and opinions so that you can make decisions with confidence, we use a variety of techniques, including surveys, video discussions and discussion groups in the world.
